Precision Medicine and the FDA
Policy researchers and biotechnology executives talked about Food and Drug Administration (FDA) approval process. The panelists focused on p… read more
Policy researchers and biotechnology executives talked about Food and Drug Administration (FDA) approval process. The panelists focused on precision medicine, which tailors treatments to the specific biochemistry of patients. The Manhattan Institute put out a paper in 2015 that showed the FDA was slow to approve new methods. close
People in this video
-
Paul Howard Senior Fellow and Director Manhattan Institute for Policy Research->Center for Medical Progress
-
Emil Kakkis M.D. Medical Geneticist
Hosting Organization
Related Video
-
Overcoming Obamacare
Phillip Klein, author of Overcoming Obamacare, moderated a panel discussion on what could be done to reverse the Afforda…
-
Health Care Policy Forum
Panelists made presentations on rising drug prices and efforts to improve the health care system and reduce costs. Then …
-
Health Care Policy, Part 2
Two former congressional staffers and other health care policy experts talked about the issues facing America’s health c…
-
Health Care Costs
Health care policy experts shared their views on lowering costs while maintaining quality. Some of the areas covered inc…